{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:01:26Z","timestamp":1792004486158,"version":"4.4.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"\n OBJECTIVES:<\/jats:title>\n Intravenous (IV) calcium salts are routinely recommended as a cardio-protective therapy in the emergency treatment of severe hyperkalemia. However, this recommendation is supported by a low level of evidence and is anecdotal. The aim of this study is to determine the effectiveness of IV Calcium (Ca) gluconate in the treatment of hyperkalemia.<\/jats:p>\n <\/jats:sec>\n \n MATERIALS AND METHODS:<\/jats:title>\n Patients with hyperkalemia and with the electrocardiogram (ECG) changes due to hyperkalemia over a 1 year period were included in this prospective observational study. Patients\u2019 ECGs were measured, before and after IV Ca-gluconate treatment and after normalization of potassium levels. Wilcoxon test and McNemar's test were used to compare the ECG parameters before and after Ca-gluconate therapy.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n The mean potassium value of 111 patients who met the inclusion criteria was 7.1 \u00b1 0.6 mmol\/l. In this study, a total of 243 ECG pathology related to hyperkalemia, 79 of which included main rhythm disorders, and the remaining 164 were nonrhythm disorders in ECG parameters, were analyzed. No statistically significant changes were determined in patients\u2019 nonrhythm ECG disorders with IV Ca-gluconate treatment (\n P<\/jats:italic>\n = 0.125). However, nine of the 79 main rhythm disorders due to hyperkalemia improved with calcium gluconate treatment and this change was statistically significant (\n P<\/jats:italic>\n < 0.004).\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSION:<\/jats:title>\n IV Ca-gluconate therapy was found to be effective, albeit to a limited degree, in main rhythm ECG disorders due to hyperkalemia, but it was not found to be effective in nonrhythm ECG disorders due to hyperkalemia. Therefore, Ca-gluconate may be effective only in the main rhythm disorders due to hyperkalemia.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/2452-2473.342812","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T05:47:36Z","timestamp":1649656056000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["The effect of calcium gluconate in the treatment of hyperkalemia"],"prefix":"10.4103","volume":"22","author":[{"given":"Nalan Gokce","family":"Celebi Yamanoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Yamanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240909","first-page":"659","article-title":"Incidence of hyperkalemia in hospitalized patients","volume":"19","author":"Shemer","year":"1983","journal-title":"Isr J Med Sci"},{"key":"R4-3-20240909","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.resuscitation.2010.08.015","article-title":"European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution","volume":"81","author":"Soar","year":"2010","journal-title":"Resuscitation"},{"key":"R5-3-20240909","first-page":"CD003235","article-title":"Emergency interventions for hyperkalaemia","volume":"2005","author":"Mahoney","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-3-20240909","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.V9101924","article-title":"Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease","volume":"9","author":"Gruy-Kapral","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R8-3-20240909","first-page":"1082","article-title":"Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients","volume":"49","author":"Mahajan","year":"2001","journal-title":"J Assoc Physicians India"},{"key":"R9-3-20240909","first-page":"503","article-title":"Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: Effect of various therapeutic approaches","volume":"74","author":"Ngugi","year":"1997","journal-title":"East Afr Med J"},{"key":"R10-3-20240909","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-4679(03)00133-1","article-title":"Levalbuterol is as effective as racemic albuterol in lowering serum potassium","volume":"25","author":"Pancu","year":"2003","journal-title":"J Emerg Med"},{"key":"R11-3-20240909","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5414\/CNP59130","article-title":"Increasing blood flow increases kt\/V (urea) and potassium removal but fails to improve phosphate removal","volume":"59","author":"Gutzwiller","year":"2003","journal-title":"Clin Nephrol"},{"key":"R12-3-20240909","first-page":"697","article-title":"Effect of calcium to reverse the electrocardiographic effects of hyperkalemia in the isolated rat heart: A prospective, dose-response study","volume":"22","author":"Bisogno","year":"1994","journal-title":"Crit Care Med"},{"key":"R13-3-20240909","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0310057X0703500117","article-title":"Resuscitation from transfusion-associated hyperkalaemic ventricular fibrillation","volume":"35","author":"Woodforth","year":"2007","journal-title":"Anaesth Intensive Care"},{"key":"R14-3-20240909","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jemermed.2004.04.006","article-title":"Electrocard\u0131ograph\u0131c manifestations: Electrolyte abnormalities","volume":"27","author":"Deborah","year":"2004","journal-title":"J Emerg Med"},{"key":"R17-3-20240909","first-page":"10","article-title":"Treatment and pathogenesis of acute hyperkalemia","volume":"1","author":"Mushiyakh","year":"2012","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"R18-3-20240909","first-page":"41","article-title":"The effect of calcium gluconate in the treatment of hyperkalemia","volume":"1","author":"Zeytin","year":"2010","journal-title":"J Emerg Med Case Rep"},{"key":"R19-3-20240909","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archinte.158.8.917","article-title":"Hyperkalemia in hospitalized patients: Causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines","volume":"158","author":"Acker","year":"1998","journal-title":"Arch Intern Med"},{"key":"R20-3-20240909","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2215\/CJN.04611007","article-title":"Retrospective review of the frequency of ECG changes in hyperkalemia","volume":"3","author":"Montague","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R21-3-20240909","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/sja.SJA_708_18","article-title":"Calcium salt administration for circulatory shock due to severe hyperkalemia","volume":"13","author":"Al Aseri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"R22-3-20240909","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1053\/ajem.2000.7344","article-title":"Electrocardiographic manifestations of hyperkalemia","volume":"18","author":"Mattu","year":"2000","journal-title":"Am J Emerg Med"},{"key":"R23-3-20240909","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ki.1990.284","article-title":"Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients","volume":"38","author":"Allon","year":"1990","journal-title":"Kidney Int"},{"key":"R24-3-20240909","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1525-139X.2001.00087.x","article-title":"Hyperkalemia in dialysis patients","volume":"14","author":"Ahmed","year":"2001","journal-title":"Semin Dial"},{"key":"R25-3-20240909","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000065375","article-title":"Therapeutic approach to hyperkalemia","volume":"92","author":"Kim","year":"2002","journal-title":"Nephron"},{"key":"R26-3-20240909","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/oxfordjournals.ndt.a091860","article-title":"Treatment of hyperkalaemia in renal failure: Salbutamol v. insulin","volume":"4","author":"Lens","year":"1989","journal-title":"Nephrol Dial Transplant"}],"container-title":["Turkish Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/2452-2473.342812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:13:14Z","timestamp":1787166794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2452-2473.342812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/2452-2473.342812","relation":{},"ISSN":["2452-2473"],"issn-type":[{"value":"2452-2473","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}